Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 1,099.22 million |
| USD 4,719.86 million | |
| % | |
|
Global Whole Genome and Exome Sequencing Market, By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Others), Products and Services (Products, Systems, Kits, Services, Sequencing Services, Data Analysis Services, Others), Applications (Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Others), End User (Research Center, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others) – Industry Trends and Forecast to 2030.
Get Exclusive Sample Copy of this Report Here
The key factors driving the global whole exome sequencing market are increasing applications in clinical diagnosis and the growing demand for diagnosing rare diseases, increasing R&D in genomics and next-generation sequencing, and rising demand for personalized medicine. For instance, an article published in the British Medical Journal in March 2022 reported that whole exome sequencing is available for highly selected patients for the routine diagnosis of rare childhood genetic diseases. The article also said that next-generation sequencing allows hundreds or thousands of genes to be sequenced quickly at a much lower cost. Due to the benefits of exome sequencing, the studied market is expected to grow over the forecast period.
Moreover, the growing adoption of personalized medicine is further estimated to provide potential opportunities for the growth of the whole genome and exome sequencing market in the forecast period.
Data Bridge Market Research analyses that the whole genome and exome sequencing market, which was USD 1,099.22 million in 2022, is likely to reach USD 4,719.86 million by 2030 and is expected to undergo a CAGR of 21.20% during the forecast period. This indicates that the market value. “Hospitals and Clinics” dominate the end-user segment of the whole genome and exome sequencing market due to the growing demand for products. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2014-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Others), Products and Services (Products, Systems, Kits, Services, Sequencing Services, Data Analysis Services, Others), Applications (Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Others), End User (Research Center, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America
|
|
Market Players Covered
|
DIGIRAD CORPORATION (U.S.), Neusoft Corporation (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), SurgicEye GmbH (Germany), Mediso Ltd. (Hungary), CMR Naviscan. (U.S.), DDD-Diagnostic A/S (Denmark), Absolute Imaging Inc. (Canada), Bartec Technologies Ltd. (U.K.), BCL X-Ray Canada Inc. (Canada), TTG Imaging Solutions, LLC (U.S.), Mirion Technologies (Capintec), Inc. (U.S.), LANDAUER (U.S.), Ashby Gorman Baker Ltd. (Belgium), Lucerno Dynamics, LLC. (U.S.), Berthold Technologies GmbH & Co.KG (Germany), Incom, Inc. (U.S.), Siemens (U.S.), Koninklijke Philips N.V. (Netherlands), Spectrum Dynamics Medical (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
The whole genome sequencing helps to provide rich information regarding single nucleotide, structural, or copy number variants, while exome sequencing often makes more sense when time or resources are limited. Exome sequencing is also known as whole exome sequencing (WES), and is a genomic procedure for sequencing all of the protein-coding regions of genes in a genome.
Drivers
The most major element driving this market's growth is the rise in cancer incidence and expanding uses of next-generation sequencing in cancer research. This is attributable to the increased adoption of the next-generation sequencing for the treatment of cancer across the globe. People are now increasingly adopting these therapies for treatment as they are more effective and have low side effects, which is boosting the growth of the market significantly. Researchers are using these techniques to uncover genetic variations associated with diseases, personalized medicine, and other critical areas of study.
The total market is being driven by a growth in acceptability of next-generation sequencing approaches for the prediction, treatment, and monitoring of a variety of chronic diseases, such as cancer. Moreover, the integration of genomic sequencing into clinical and diagnostic settings has expanded the market. It is being used for the diagnosis of various genetic disorders and as a screening tool in prenatal and new-born care.
The cost of sequencing has significantly decreased over the years, making it more accessible to researchers, clinicians, and patients. This cost reduction has widened the market's reach and increased adoption. Thus, when compared to whole genome sequencing, whole exome sequencing has a lower cost which will further anticipated to propel the growth of the market.
Opportunity
Continuous improvements in sequencing technologies and bioinformatics tools have enhanced the speed, accuracy, and efficiency of whole genome and exome sequencing. This, in turn, will extend profitable opportunities for the market players in the forecast period of 2023 to 2030 by enabling more comprehensive and cost-effective sequencing.
Moreover, it is anticipated that the market for whole genome and exome sequencing will exhibit lucrative growth with the ongoing developments in genomic research have expanded the applications of whole genome and exome sequencing.
Restraint/Challenge
On the other hand, the dearth of skilled professionals and high reliability on grants is further projected to impede the growth of the whole genome and exome sequencing market in the targeted period. Moreover, the ethical and legal concerns regarding to whole exome sequencing might further challenge the growth of the whole genome and exome sequencing market in the forecast period of 2023-2030.
This whole genome and exome sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the whole genome and exome sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
The whole genome and exome sequencing market is segmented on the basis of technology, products and services, applications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
Products and Services
Applications
End user
The whole genome and exome sequencing market is analyzed, and market size insights and trends are provided by country, technology, products and services, applications, and end users, as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Brazil, Argentina, rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and rest of Middle East and Africa.
North America is expected to dominate the whole genome and exome sequencing market due to the rise in the incidence of genetic and chronic disorders, including cancer. Furthermore, the growing geriatric population and increasing demand for targeted and personalized medicine will further boost the growth of the whole genome and exome sequencing market in the region during the forecast period.
Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023 to 2030 due to the regular government funding. Moreover, the growing numbers of conferences regarding the whole exome sequencing technique is further anticipated to propel the growth of the whole genome and exome sequencing market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The whole genome and exome sequencing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for whole genome and exome sequencing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the whole genome and exome sequencing market. The data is available for historic period 2010-2020.
The whole genome and exome sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to whole genome and exome sequencing market.
Some of the major players operating in the whole genome and exome sequencing market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.